Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US coverage decision "will provide sustained ICDs (implantable cardioverter defibrillators) growth"

This article was originally published in Clinica

Executive Summary

The US Centers for Medicare & Medicaid Services (CMS) has finally agreed to expand its coverage of implantable cardioverter defibrillators (ICDs) to nearly 500,000 potential beneficiaries deemed at possible risk of experiencing sudden cardiac arrest. "By increasing the use of defibrillators, we are striking a blow against the leading cause of death among older Americans," said CMS administrator Mark McClellan.

Topics

UsernamePublicRestriction

Register

MT054188

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel